Equities

Fleury SA

Fleury SA

Actions
Health CareHealth Care Providers
  • Price (BRL)19.08
  • Today's Change0.07 / 0.37%
  • Shares traded292.80k
  • 1 Year change-9.74%
  • Beta0.6190
Data delayed at least 15 minutes, as of Oct 06 2022 15:15 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.

  • Revenue in BRL (TTM)4.25bn
  • Net income in BRL346.73m
  • Incorporated1964
  • Employees16.70k
  • Location
    Fleury SAAv. General Valdomiro de Lima508, JabaquaraSAO PAULO 04.344-070BrazilBRA
  • Phone+55 1 150351986
  • Fax+55 1 150147425
  • Websitehttp://www.fleury.com.br/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
FLRY3:SAO since
announced
Transaction
value
Instituto Hermes Pardini SAAnnounced30 Jun 202230 Jun 2022Announced35.90%485.11m
Marcelo Magalhaes Diagnosticos SAAnnounced18 Oct 202118 Oct 2021Announced-10.72%--
Laboratorio Marcelo Magalhaes SAAnnounced18 Oct 202118 Oct 2021Announced-10.72%70.41m
Data delayed at least 15 minutes, as of Oct 06 2022 15:15 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kora Saude Participacoes SA1.74bn-83.33m1.90bn4.50k--1.51118.621.09-0.135-0.1352.531.620.444915.723.12---1.78---2.20--25.27---4.01--1.581.190.6463--106.09---501.47------
Centro de Imagem Diagnosticos SA1.11bn-55.22m2.49bn----2.1634.662.24-0.4686-0.46869.419.720.426467.455.53---1.800.2191-2.280.27331.9626.77-4.220.48810.80620.52390.4876--22.373.6294.23---0.9897--
Instituto Hermes Pardini SA2.05bn194.06m2.82bn7.10k14.002.898.581.381.531.5316.217.440.948925.164.59288,721.109.019.8312.3213.0729.0129.729.4910.510.9799268.370.366532.0932.9217.1668.7915.7524.53--
Oncoclinicas do Brasil Srvcs Mdcs SA3.16bn104.78m3.19bn--30.211.7611.471.010.21150.21156.373.640.662325.624.04--2.80--4.01--34.14--4.22--1.912.220.5169--32.77--70.62------
Hospital Mater Dei Sa1.31bn121.05m3.34bn3.68k22.771.9917.322.560.38210.38213.764.380.36919.533.30--3.76--4.18--36.63--10.18--2.883.740.5264--42.69--99.49------
Odontoprev SA1.85bn446.01m5.02bn2.03k11.244.219.842.710.78280.78283.242.090.9103179.2213.28--21.9121.6734.1530.7062.0660.2924.0721.480.7308--0.039861.274.376.155.3311.9830.905.95
Fleury SA4.25bn346.73m5.64bn16.70k16.183.097.221.331.091.0913.395.730.705241.185.27265,527.305.806.967.578.4328.4029.538.2210.631.353.350.663375.7230.3213.0636.188.8717.57-4.79
Diagnosticos da America SA11.86bn-176.54m10.61bn18.14k--1.4111.780.8945-0.3014-0.301420.5013.330.553920.994.58---0.81540.1711-1.070.221829.2030.79-1.470.29261.211.130.62211,170.8548.0127.93-50.24--22.4242.34
Data as of Oct 06 2022. Currency figures normalised to Fleury SA's reporting currency: Brazilian Real BRL

Institutional shareholders

15.39%Per cent of shares held by top holders
HolderShares% Held
Bram Bradesco Asset Management S/A DTVMas of 31 May 20227.68m2.41%
The Vanguard Group, Inc.as of 09 Sep 20227.46m2.35%
Capital Research & Management Co. (World Investors)as of 30 Jun 20225.54m1.74%
Handelsbanken Fonder ABas of 31 Aug 20225.18m1.63%
BlackRock Brasil Gestora de Investimentos Ltda.as of 08 Sep 20224.86m1.53%
APG Asset Management NVas of 31 Dec 20214.58m1.44%
Van Eck Associates Corp.as of 08 Sep 20223.98m1.25%
RBC Global Asset Management (UK) Ltd.as of 29 Jul 20223.84m1.21%
BlackRock Fund Advisorsas of 08 Sep 20223.03m0.95%
Capital Research & Management Co. (International Investors)as of 30 Jun 20222.83m0.89%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.